TASIN-1

N/A

Report date: 2024/03/15 17:36:43
NME

Base Information

Drug NameTASIN-1
Drug Alias NameTASIN-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenomatous polyposis coli protein inhibitors
TargetsAdenomatous polyposis coli protein
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical Center
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A